AKESO INC (AKESF:OTCMKTS)
$14.2163 -0.7837 (-5.2247%)
Analysed AKESO INC (AKESF:OTCMKTS) News Sources
Discover 3 Asian Growth Companies With Insider Ownership Up To 23%
30-04-2026
yahoo.com
This is why Summit Therapeutics (SMMT) is one of the Best Stocks to buy in a Rising Market
02-05-2026
yahoo.com
H.C. Wainwright Reduced its Price Goal on Summit Therapeutics Inc. (SMMT)
13-05-2026
yahoo.com
INOVIO Reports First Quarter 2026 Financial Results and Recent Business Highlights
13-05-2026
yahoo.com
Inovio Pharmaceuticals, Inc. Q1 2026 Earnings Call Summary
14-05-2026
moby.co
Phase II Data from a Randomized Double-Blind Trial of Ligufalimab (Anti-CD47) Combination Therapy in Frontline AML Published at EHA 2026
15-05-2026
yahoo.com
Is It Time To Reconsider Akeso (SEHK:9926) After Recent Share Price Pullback?
17-05-2026
yahoo.com
ASCO26: 5 data snapshots ahead of the year’s biggest cancer drug meeting
22-05-2026
biopharmadive.com
Here's Why You Should Add SMMT Stock to Your Portfolio Now
22-05-2026
yahoo.com
Over 40 Studies Featuring Akeso's Innovative Oncology Agents to Be Presented at ASCO 2026: Ivonescimab's HARMONi-6 Overall Survival Data Selected for Plenary Session
26-05-2026
yahoo.com
What is the current price of AKESO INC (AKESF:OTCMKTS)?
The current price of AKESO INC (AKESF:OTCMKTS) is $14.2163.
AKESO INC (AKESF:OTCMKTS) absolute price change since previous trading day?
The absolute price change of AKESO INC (AKESF:OTCMKTS) since the previous trading day is $-0.7837.
AKESO INC (AKESF:OTCMKTS) percentage price change since previous trading day?
The percentage price change of AKESO INC (AKESF:OTCMKTS) since the previous trading day is -5.2247%.
What is the most recent average sentiment score for AKESO INC (AKESF:OTCMKTS)?
The most recent average sentiment score for AKESO INC (AKESF:OTCMKTS) is 68 out of 100.
What is the most recent average sentiment for AKESO INC (AKESF:OTCMKTS)?
The most recent sentiment for AKESO INC (AKESF:OTCMKTS) is .
SEC-8K** Filing Available For AKESO INC (AKESF:OTCMKTS)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.